Ledger.Open graph →

SEC Form D · Amendment · filed March 10, 2016

Gemphire Therapeutics Inc

Offering

$9.0M

Sold

$5.6M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

NORTHVILLE, MI

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (32)

Kenneth Kousky · Midland, MIDirector Charles Bisgaier · Northville, MIExec · Director Margaret Mcshane · Northville, MIExec P. K. Hawryluk · Carmel, INDirector Daniela Oniciu · Northville, MIExec Seth K. Reno · Northville, MIExec David Lowenschuss · Northville, MIExec · Director Jeffrey K. Mathiesen · Northville, MIExec Pedro K. Lichtinger · New York, NYDirector Mina Sooch · Northville, MIExec · Director Andy Sassine · Rancho Santa Fe, CADirector Paul Nasser · BOSTON, MADirector Eric O'Brien · SAN MATEO, CAExec William Alaynick · San Diego, CAExec · Director Kenneth Hood · San Diego, CAExec · Director Ulf Lindskog · Uppsala, V7Director Lena Soderstrom · Uppsala, V7Exec Lawrence Chavez · Albuquerque, NMExec Vanessa Barrett · Grand Cayman, Cayman IslandsDirector Amir Belson · Menlo Park, CAExec · Director Deborah L. Machovec · Wahoo, NEDirector Hurley Doddy · George Town, Grand Cayman, Cayman IslandsDirector Marc A. Weiser · Ann Arbor, MIExec · Director Pravin V. Gandhi · Fort Mumbai, K7Exec · Director Bala V. Deshpande · Timonium, MDExec · Director George A. Parris · Audubon, IAExec · Director Jon Cheek · SAN FRANCISCO, CAExec Jt Michelson · Albuquerque, NMExec Alan I. Bossin · Hamilton, BermudaDirector Kim H. Ng · Greenwood Village, COExec Richard F. Clement, Jr · Greenwood Village, COExec Alexander F. Bayer · GREENWOOD VILLAGE, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗